Health
0
Comments
FDA Approves Flibanserin 'Little Pink Pill' Amid Controversy
The FDA has given the green light to Addyi, also known as the 'little pink pill' or flibanserin, designed to boost women's sexual desire. The approval follows an intense lobbying campaign and comes with several prescribing restrictions. Although hailed as a breakthrough for treating Hypoactive Sexual Desire Disorder (HSDD), the drug's effectiveness and safety remain points of contention among experts.
About
Health
Latest Posts
The Connection Between Muscle Stiffness and Chronic Pain Conditions
By Orion Kingsworth Jun 18, 2023
Understanding Priligy Tablets for Premature Ejaculation Treatment: A Comprehensive Drug Guide
By Orion Kingsworth Mar 22, 2024
Amoxicillin for Tonsillitis: Dosage, Effectiveness, and Side Effects
By Orion Kingsworth May 29, 2023
